Three Ways of Combining Genotyping and Resequencing in Case-Control Association Studies
Open Access
- 20 December 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (12) , e14318
Abstract
We describe three statistical results that we have found to be useful in case-control genetic association testing. All three involve combining the discovery of novel genetic variants, usually by sequencing, with genotyping methods that recognize previously discovered variants. We first consider expanding the list of known variants by concentrating variant-discovery in cases. Although the naive inclusion of cases-only sequencing data would create a bias, we show that some sequencing data may be retained, even if controls are not sequenced. Furthermore, for alleles of intermediate frequency, cases-only sequencing with bias-correction entails little if any loss of power, compared to dividing the same sequencing effort among cases and controls. Secondly, we investigate more strongly focused variant discovery to obtain a greater enrichment for disease-related variants. We show how case status, family history, and marker sharing enrich the discovery set by increments that are multiplicative with penetrance, enabling the preferential discovery of high-penetrance variants. A third result applies when sequencing is the primary means of counting alleles in both cases and controls, but a supplementary pooled genotyping sample is used to identify the variants that are very rare. We show that this raises no validity issues, and we evaluate a less expensive and more adaptive approach to judging rarity, based on group-specific variants. We demonstrate the important and unusual caveat that this method requires equal sample sizes for validity. These three results can be used to more efficiently detect the association of rare genetic variants with disease.Keywords
This publication has 25 references indexed in Scilit:
- Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast CancerPLOS ONE, 2009
- Discovery of Rare Variants via Sequencing: Implications for the Design of Complex Trait Association StudiesPLOS Genetics, 2009
- A Groupwise Association Test for Rare Mutations Using a Weighted Sum StatisticPLOS Genetics, 2009
- Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discoveryGenome Medicine, 2009
- Genetic Mapping in Human DiseaseScience, 2008
- Increasing the Power and Efficiency of Disease-Marker Case-Control Association Studies through Use of Allele-Sharing InformationThe American Journal of Human Genetics, 2004
- ATM missense mutations are frequent inpatients with breast cancerCancer Genetics and Cytogenetics, 2003
- Searching for genetic determinants in the new millenniumNature, 2000
- Scanning by DOVAM-S Detects All Unique Sequence Changes in Blinded Analyses: Evidence that the Scanning Conditions Are GenericBioTechniques, 2000
- Effect of allelic heterogeneity on the power of the transmission disequilibrium testGenetic Epidemiology, 2000